A team of researchers says it has created what could become the world’s first viable vaccine against Alzheimer’s disease, although others in the field remain skeptical.
An article published online earlier this month in Nature’s Scientific Reports describes the study, which was conducted on mice, as “promising.” The vaccine simultaneously targets beta-amyloid and tau, the two proteins that have been implicated in the brain plaques and tangles, respectively, that characterize Alzheimer’s.
Read Full Article »